ZOLOFT^®(sertraline, as hydrochloride)VIATRISHK Reg. No. HK-68926 (09 Dec, 2025)

Composition:³

• ZOLOFT^® is available in 100 mg tablets, along with other dosage forms

Indication:³

ZOLOFT^® is a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of:

• Major depressive disorder (MDD)

• Obsessive-compulsive disorder (OCD)

• Panic disorder (PD)

• Post-traumatic stress disorder (PTSD)

• Social anxiety disorder (SAD)

• Premenstrual dysphoric disorder (PMDD)

References

3. FDA. Highlights of Prescribing Information. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019839s74s86s87_20990s35s44s45lbl.pdf. [Accessed 23 December 2025].